Cisen Pharmaceutical Co., Ltd. (SHA:603367)
China · Delayed Price · Currency is CNY 29.99
-0.02 (-0.07%)
Aug 1, 2025, 2:45 PM CST
Accolade Market Cap
Cisen Pharmaceutical has a market cap or net worth of 13.67 billion as of August 1, 2025. Its market cap has increased by 115.18% in one year.
Market Cap
13.67B
Enterprise Value
10.98B
Revenue
3.75B
Ranking
n/a
PE Ratio
27.96
Stock Price
$29.99
Market Cap Chart
Since September 29, 2017, Cisen Pharmaceutical's market cap has increased from 7.61B to 13.67B, an increase of 79.57%. That is a compound annual growth rate of 7.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 13.67B | 119.72% |
| Dec 31, 2024 | 6.22B | -5.76% |
| Dec 29, 2023 | 6.60B | 16.46% |
| Dec 30, 2022 | 5.67B | -5.19% |
| Dec 31, 2021 | 5.98B | -4.03% |
| Dec 31, 2020 | 6.23B | -16.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 419.64B |
| Shenzhen Mindray Bio-Medical Electronics | 279.61B |
| WuXi AppTec | 274.21B |
| Sichuan Biokin Pharmaceutical | 123.27B |
| Zhangzhou Pientzehuang Pharmaceutical., | 120.05B |
| Aier Eye Hospital Group | 119.45B |
| Shanghai United Imaging Healthcare | 109.31B |
| Yunnan Baiyao Group Co.,Ltd | 100.06B |